[Brazilian guideline for the treatment of patients with opioids dependence syndrome].
There is a relatively low prevalence of opioid use in Brazil, particularly involving the non-medical use of codeine and opiate-containing syrups. However, opioid dependence syndrome shows a significant total impact on mortality and morbidity. Over the past 20 years, scientific progress has changed our understanding of the nature of opioid addiction and its various possible treatments. Addiction is a chronic illness treatable if the treatment is well-delivered and tailored to the needs of the particular patient. There is indeed an array of treatments that can effectively reduce drug use, help manage drug cravings, prevent relapses and restore people to productive social functioning. The treatment of drug addiction will be part of long-term, medical, psychological, and social perspectives. This guideline aims at providing guidance to psychiatrists and other mental health professionals who care for patients with opioid dependence syndrome. It comments on the somatic and psychosocial treatment that is used for such patients, and reviews scientific evidences and their strength. Also, the essential historical, epidemiological and neurobiological aspects of opioid dependence are reviewed.
Baltieri
Danilo Antonio
DA
Departamento de Dependência Química, Associação Brasileira de Psiquiatria, Brazil.
Strain
Eric C
EC
Dias
João Carlos
JC
Scivoletto
Sandra
S
Malbergier
André
A
Nicastri
Sérgio
S
Jerônimo
Cláudio
C
Andrade
Arthur Guerra de
AG
D001938:Brazil; D006801:Humans; D009293:Opioid-Related Disorders / Q000145:classification / Q000188:drug therapy* / Q000628:therapy; D013577:Syndrome